Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Unifirst Corp
UNF
$5.23B
| $895K | ﹤0.01% |
8,200
+3,487
| +74% | +$365K |
|
4102
Braskem
BAK
$917M
| $893K | ﹤0.01% |
69,151
-199,535
| -74% | -$2.55M |
|
|
LDRH
4103
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $893K | ﹤0.01% |
35,027
-19,670
| -36% | -$412K |
|
|
OME
4104
DELISTED
Omega Protein
OME
| $892K | ﹤0.01% |
52,641
+20,940
| +66% | +$429K |
|
4105
CALL
Cencora
COR
$62.1B
| $891K | ﹤0.01% |
10,300
-4,100
| -28% | -$365K |
|
|
KCG
4106
CALL
DELISTED
KCG Holdings, Inc.
KCG
| $891K | ﹤0.01% |
74,600
-6,600
| -8% | -$73.2K |
|
4107
Franklin Electric
FELE
$4.87B
| $890K | ﹤0.01% |
27,678
-24,725
| -47% | -$702K |
|
4108
CALL
Regions Financial
RF
$27.3B
| $890K | ﹤0.01% |
113,400
-57,100
| -33% | -$459K |
|
4109
PUT
Murphy Oil
MUR
$5.29B
| $889K | ﹤0.01% |
35,300
+9,500
| +37% | +$190K |
|
|
CVT
4110
DELISTED
CVENT, INC.
CVT
| $889K | ﹤0.01% |
41,569
+10,926
| +36% | +$258K |
|
4111
Omeros
OMER
$920M
| $888K | ﹤0.01% |
57,886
-115,789
| -67% | -$1.41M |
|
4112
PUT
Trinity Industries
TRN
$2.58B
| $888K | ﹤0.01% |
67,367
+7,640
| +13% | +$107K |
|
|
MWW
4113
DELISTED
Monster Worldwide Inc
MWW
| $887K | ﹤0.01% |
272,199
-60,594
| -18% | -$236K |
|
|
USG
4114
CALL
DELISTED
Usg
USG
| $886K | ﹤0.01% |
35,700
-4,000
| -10% | -$83.1K |
|
4115
FTAI Aviation
FTAI
$23.3B
| $885K | ﹤0.01% |
104,194
+2,318
| +2% | +$19.4K |
|
4116
Insmed
INSM
$21.7B
| $884K | ﹤0.01% |
69,768
+59,170
| +558% | +$778K |
|
|
ACRE
4117
Ares Commercial Real Estate
ACRE
$259M
| $883K | ﹤0.01% |
80,641
+26,081
| +48% | +$272K |
|
4118
MiMedx Group
MDXG
$608M
| $883K | ﹤0.01% |
101,097
+69,939
| +224% | +$581K |
|
4119
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $883K | ﹤0.01% |
14,430
+472
| +3% | +$28.8K |
|
4120
CALL
Warner Bros
WBD
$64.7B
| $879K | ﹤0.01% |
30,700
+7,500
| +32% | +$201K |
|
4121
CALL
Toronto Dominion Bank
TD
$201B
| $876K | ﹤0.01% |
20,300
| – | – |
|
|
MITT
4122
TPG Mortgage Investment Trust
MITT
$223M
| $875K | ﹤0.01% |
22,312
-7,031
| -24% | -$257K |
|
|
ALIM
4123
PUT
DELISTED
Alimera Sciences
ALIM
| $875K | ﹤0.01% |
+33,333
| New | +$1.04M |
|
|
PGH
4124
DELISTED
Pengrowth Energy Corporation
PGH
| $873K | ﹤0.01% |
666,911
-56,177
| -8% | -$44.9K |
|
|
DWA
4125
CALL
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $871K | ﹤0.01% |
34,900
+14,300
| +69% | +$352K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.